RLAY DCF Valuation - Relay Therapeutics Inc

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 14.17 USD 4.73%

Market Cap: $2.5B

	Relay Therapeutics Inc NASDAQ:RLAY	US
	Central Japan Railway Co TSE:9022	JP
	EQT Corp NYSE:EQT	US
	Myriad Genetics Inc NASDAQ:MYGN	US
	Peet Ltd ASX:PPC	AU
	ZIM Integrated Shipping Services Ltd NYSE:ZIM	IL
	Applovin Corp NASDAQ:APP	US
	Knot Offshore Partners LP NYSE:KNOP	UK
	Kimco Realty Corp NYSE:KIM	US
	Takamatsu Construction Group Co Ltd TSE:1762	JP
	Essex Property Trust Inc NYSE:ESS	US
	Pultegroup Inc NYSE:PHM	US
	Asia Vital Components Co Ltd TWSE:3017	TW

RLAY's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.